At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4588 Fractional Shares
Closed Independence Day 07-02 16:00:00 EDT
1,958.76
+0.21
+0.01%
High1,975.91Low1,944.79Vol6.39B
Open1,961.78D1 Closing1,958.55Amplitude1.59%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O896.02BT/O Rate--Tradable Shares0.00
P/B5.316222ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

‘Take the Plunge,’ Says Analyst About Netflix Stock
TIPRANKS  ·  06-29
‘Take the Plunge,’ Says Analyst About Netflix Stock
Notice of Proposed Sale of Securities-xyz.n
Reuters  ·  06-29
Notice of Proposed Sale of Securities-xyz.n
The Company Cleaning up the Reflecting Pool Says it Has 'nothing to Hide'
Dow Jones  ·  06-29
The Company Cleaning up the Reflecting Pool Says it Has 'nothing to Hide'
Hofseth Biocare Places 111,154,608 Shares in Private Placement at NOK 1.3, Raising NOK 144.5 Million
Reuters  ·  06-29
Hofseth Biocare Places 111,154,608 Shares in Private Placement at NOK 1.3, Raising NOK 144.5 Million
Healius Signs National Agreement Framework With Ramsay Health Care
MT Newswires Live  ·  06-29
Healius Signs National Agreement Framework With Ramsay Health Care
Microsoft Stock: Value Trap or Buying Opportunity?
TIPRANKS  ·  06-29
Microsoft Stock: Value Trap or Buying Opportunity?
Vital Healthcare Manager’s Stake in Trust Falls as Control Rights Narrow
TIPRANKS  ·  06-29
Vital Healthcare Manager’s Stake in Trust Falls as Control Rights Narrow
Bridgebio Says Phase 3 Propel 3 Trial Shows Oral Infigratinib Boosts Growth in Children with Achondroplasia
Reuters  ·  06-29
Bridgebio Says Phase 3 Propel 3 Trial Shows Oral Infigratinib Boosts Growth in Children with Achondroplasia
Bridgebio Announces Publication in the New England Journal of Medicine of Phase 3 Propel 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
THOMSON REUTERS  ·  06-29
Bridgebio Announces Publication in the New England Journal of Medicine of Phase 3 Propel 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
GlobeNewswire  ·  06-29
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
How Micron Has Become One of the Most Profitable Companies in the U.S.
Dow Jones  ·  06-29
How Micron Has Become One of the Most Profitable Companies in the U.S.
Williams in Talks on $5.5 Billion Deal for Momentum Midstream, Bloomberg Reports
Reuters  ·  06-29
Williams in Talks on $5.5 Billion Deal for Momentum Midstream, Bloomberg Reports
Zillow Group (ZG) Launches A New Digital Hub On Undervalued Growth Narrative
Simply Wall St.  ·  06-29
Zillow Group (ZG) Launches A New Digital Hub On Undervalued Growth Narrative
3 ASX Dividend Stocks Yielding Up To 4.7%
Simply Wall St.  ·  06-29
3 ASX Dividend Stocks Yielding Up To 4.7%
Is Starbucks (SBUX) Fully Valued Following Its Smaller Store Expansion Plan?
Simply Wall St.  ·  06-29
Is Starbucks (SBUX) Fully Valued Following Its Smaller Store Expansion Plan?
Is Embedding Climate Analytics Into Broking Workflows Altering The Investment Case For Willis Towers Watson (WTW)?
Simply Wall St.  ·  06-29
Is Embedding Climate Analytics Into Broking Workflows Altering The Investment Case For Willis Towers Watson (WTW)?
Billionaire Ken Griffin Slashed 40% of His Stake in Palantir Stock — Should You Do the Same?
TIPRANKS  ·  06-29
Billionaire Ken Griffin Slashed 40% of His Stake in Palantir Stock — Should You Do the Same?
Asia Morning Call-global Markets
Reuters  ·  06-29
Asia Morning Call-global Markets
Reuters Sports Schedule at 7:30 P.m. Gmt/ 2:30 P.m. Et
Reuters  ·  06-29
Reuters Sports Schedule at 7:30 P.m. Gmt/ 2:30 P.m. Et
Williams Said to Near $5.5 Billion Deal for Momentum Midstream - Bloomberg News
THOMSON REUTERS  ·  06-29
Williams Said to Near $5.5 Billion Deal for Momentum Midstream - Bloomberg News

Introduction

Company Name.
BK4588
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--